| 1 |
|
A tale of 2 (or more) tails: PECAM-1 regulation of GPIb-IX-V signaling/
|
Lopez, J. A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2 |
|
Tackling T-cell tumors/
|
Lyerly, H. K
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 3 |
|
Targeted disruption of oncostatin M receptor results in altered hematopoiesis/
|
Tanaka, M
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 4 |
|
Targeting CD20/
|
Winter, J. N
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 5 |
|
Targeting DCs to induce regulatory T cells in vivo/
|
Truitt, R. L
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 6 |
|
Targeting of the collagen-binding site on glycoprotein VI is not essential for in vivo depletion of the receptor/
|
Schulte, V
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 7 |
|
Targeting of the N-terminal coiled coil oligomerization interface of BCR interferes with the transformation potential of BCR-ABL and increases sensitivity to STI571/
|
Beissert, T
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 8 |
|
T-cell developmental blockage by tachykinin antagonists and the role of hemokinin 1 in T lymphopoiesis/
|
Zhang, Y
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 9 |
|
T-cell differentiation: Notch another step/
|
Scadden, D. T
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 10 |
|
T-cell epitopes within the complementarity-determining and framework regions of the tumor-derived immunoglobulin heavy chain in multiple myeloma/
|
Hansson, L
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 11 |
|
T-cell interaction with ICAM-1/ICAM-2 double-deficient brain endothelium in vitro: the cytoplasmic tail of endothelial ICAM-1 is necessary for transendothelial migration of T cells/
|
Lyck, R
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 12 |
|
TCR gene therapy of leukemia/
|
Stauss, H. J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 13 |
|
Tec regulates platelet activation by GPVI in the absence of Btk/
|
Atkinson, B. T
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 14 |
|
Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival/
|
Wu, K.-D
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 15 |
|
Testing recombinant adeno-associated virus-gene loading of dendritic cells for generating potent cytotoxic T lymphocytes against a prototype self-antigen, multiple myeloma HM1.24/
|
Chiriva-Internati, M
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 16 |
|
Tetrocarcin-A-induced ER stress mediates apoptosis in B-CLL cells via a Bcl-2-independent pathway/
|
Anether, G
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 17 |
|
TFPI and venous thrombosis/
|
Bauer, K. A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 18 |
|
TGF-beta signaling-deficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro/
|
Larsson, J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 19 |
|
Thalidomide, age, and future use in multiple myeloma/
|
Hussein, M. A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 20 |
|
Therapeutic effect of idiotype-specific CD4^+ T cells against B-cell lymphoma in the absence of anti-idiotypic antibodies/
|
Lundin, K. U
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|